Mammography SPECT With Rotating Slant Hole Collimator
NCT00328354 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-04-06
Summary
The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Benjamin Tsui, Ph.D. · Johns Hopkins University
Eligibility
- Min Age
- 35 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
NCT02325349 ·Status: TERMINATED ·Phase: PHASE2
-
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
NCT02608216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
NCT05222269 ·Status: TERMINATED ·Phase: PHASE2
-
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
NCT05096234 ·Status: TERMINATED ·Phase: PHASE1
-
Dual Time Point PET Imaging in Lymphoma
NCT00297557 ·Status: UNKNOWN
-
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
NCT04252859 ·Status: TERMINATED ·Phase: PHASE2
-
PSMA PET and MRI in Gynecological Cancers
NCT03302156 ·Status: TERMINATED ·Phase: PHASE2
-
64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets
NCT02735798 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Advanced MRI Sequences for Radiation Therapy Treatment Planning
NCT02340715 ·Status: COMPLETED
-
64Cu-LLP2A for Imaging Hematologic Malignancies
NCT06636175 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
NCT03561324 ·Status: WITHDRAWN ·Phase: NA
-
18F-FLT PET Imaging in Patients With Advanced Melanoma
NCT02891616 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT02042924 ·Status: TERMINATED ·Phase: NA
-
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
NCT01269593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Positron Emission Tomography in Patients With Breast Cancer
NCT00001385 ·Status: COMPLETED
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA
-
Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study
NCT06753513 ·Status: NOT_YET_RECRUITING
-
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
NCT03286972 ·Status: TERMINATED
-
68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers
NCT05346276 ·Status: COMPLETED
-
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma
NCT02776891 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner
NCT05381077 ·Status: UNKNOWN ·Phase: NA
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
NCT04493411 ·Status: TERMINATED ·Phase: NA